PAIN RELIEVER USAGE IN THE TREATMENT OF MUSCULOSKELETAL DISEASES: A CROSS-SECTIONAL STUDY IN A CENTRAL HOSPITAL IN VIETNAM
 
More details
Hide details
1
Pham Ngoc Thach University of Medicine
2
University of Medicine Pham Ngoc Thach, Ho Chi Minh City 70000
3
Pham Ngoc Thach University of Medicine
4
Pham Ngoc Thach University of Medicine, Ho Chi Minh City 70000
Online publication date: 2018-05-16
Publication date: 2018-05-16
 
Eurasian J Anal Chem 2018;13(3):emEJAC04006
 
KEYWORDS
ABSTRACT
Introduction: Musculoskeletal diseases tend to develop in the later decades of life. As investigated in 2010, 60% of those over age 65 suffered from musculoskeletal diseases. This is an under-considered issue that causes difficulty in affected patients’ daily livesand incurs a high economic burden. Anti-inflammatory agents and pain relievers are commonly used to treat these chronic diseases. However, to date in Vietnam, there has not been any official research or data collectedon the usage of these medicine in the treatment of musculoskeletal diseases. Objectives: This study aimed to investigate pain reliver usage, the most common adverse reactions to these medications, and the satisfaction of patients prescribed these drugs. Methods: This was the cross-sectional study conducted from January 2018 to May 2018 in Thong Nhat Hospital in Ho Chi Minh City, Vietnam. The sample size was estimated at 350 patients who were treated in outpatient departments for musculoskeletal diseases. Results: There were twelve brand names containing six active ingredientsthat were used in the treatment of musculoskeletal diseases. NSAIDs were the most commonly prescribed medications (67.14%); of these, 55.32% were selective COX-2 inhibitors. Of the 22.86% of patients who sufferedadverse effects, 77.50% of these were gastrointestinal upsets. The majority of patients presented a good evaluation after using pain relievers. Conclusion:Future research should be conducted on the adverse effects of NSAIDs that are selective COX-2 inhibitors. Policymakers should establish guidelines for pain reliever management in hospitals.
eISSN:1306-3057